IE66904B1 - Qantification of nucleic acid molecules and the reagent Kit Used - Google Patents

Qantification of nucleic acid molecules and the reagent Kit Used

Info

Publication number
IE66904B1
IE66904B1 IE49687A IE49687A IE66904B1 IE 66904 B1 IE66904 B1 IE 66904B1 IE 49687 A IE49687 A IE 49687A IE 49687 A IE49687 A IE 49687A IE 66904 B1 IE66904 B1 IE 66904B1
Authority
IE
Ireland
Prior art keywords
fragment
gene
nucleic acid
test
standard
Prior art date
Application number
IE49687A
Other versions
IE870496L (en
Inventor
Marjut Ranki
Hans Soderlund
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of IE870496L publication Critical patent/IE870496L/en
Publication of IE66904B1 publication Critical patent/IE66904B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention is related to the quantification of certain nucleic acid molecules, particularly the degree of amplification of genes and/or corresponding messenger RNA molecules using the sandwich or solution hybridization method, and the reagent kit used. The determination is carried out by comparing the number of the test nucleic acid molecules potentially present in several copies in given unit to the number of chosen standard nucleic acid molecules advantageously present in a constant number per same unit. [CA1287558C]

Description

The invention relates to the quantification of certain nucleic acid molecules, particularly the degree of amplification of genes and/or corresponding messenger RNA molecules using the sandwich or solution hybridization method, and the reagent kit used.
The number of copies of individual genes in the genome is usually constant. In some instances there is only one gene per haploid genome and in others several. under certain circumstances the number of copies may change. The amplification of certain genes has for example been found to be associated with the development of cancer. It is also known that external factors such as pharmaceuticals and metals cause certain genes to be amplified. For the development of a disease, the faulty or enhanced expression level of a gene, such as an oncogene, i.e. the quantity of messenger RNA in the cell, is of major importance. Increased numbers of some chromosomes is the cause of certain hereditary diseases or other disturbances, whereas some hereditary diseases only require duplication of one recessive gene. In all such instances it is important to determine the number of chromosomes or genes present.
The number of certain DNA molecules, for example the degree of amplification of given genes, is currently determined by digesting the extracted DNA to be studied by means of restriction enzymes and by separating the nucleotide fragments according to length by agarose gel electrophoresis. Subsequently the single-stranded DNA is transferred and affixed to a nitrocellulose filter, where hybridization takes place using the gene to be studied or part of the gene as a probe. The results are obtained by autoradiography (Southern, J. Mol. Biol 98, pp. 503-517, 1975). In each parallel analysis, the quantity of cellular DNA is the same.
The intensities of the hybridisation bands, i.e. the signals are compared and the ratios between the copy numbers of the genes under study in the test samples are deduced. The method only yields approximate results. Likewise, RNA is measured using Northern-blotting or dot-blotting methods. These methods are quantitatively very inaccurate (Thomas, Methods in Enzymol., 100, pp. 255-266, 1983).
Known methods, such as the Southern and Northern blotting methods, are slow and difficult to perform. Since they only yield approximate results their diagnostic value is doubtful in cases in which it is important to know the number of certain nucleic acid molecules per given unit, such as a cell.
The present invention now provides an accurate and rapid quantitative method of nucleic acid molecule determination which is also faster and simpler to perform than those currently used. It can be used for cancer and prenatal diagnostics, for detecting agents which cause gene amplification and for demonstrating the development of e.g. drug resistance as well as for the determination of the expression level of messenger RNA.
In accordance with the present invention, there is provided a quantitative method for the determination of nucleic acid molecules by sandwich solution hybridization, the method comprising determining the number of nucleic acid molecules per given unit by comparing the number of test nucleic acid molecules potentially present in several copies in the unit to the number of chosen standard nucleic acid, molecules advantageously present in a constant number in the same unit, wherein the nucleic acids present in the sample (a) are rendered, if necessary, into a form whereby they can participate in the hybridization reaction, any nucleic acids potentially disturbing the hybridisation reaction being rendered, if necessary, into a form whereby they cannot interfere with the hybridisation test; and (b) are brought into contact, either undivided or, when necessary divided, with at least one test probe pair sufficiently homologous to the nucleic acid potentially present in several copies and with at least one chosen and suitable standard probe pair sufficiently homologous to the nucleic acid molecule advantageously present in a constant number, the detector probes of the test probe pair and standard probe pair being labelled with a detectable label and the capturing probes having been affixed to a suitable carrier or a substance having been affixed to the capturing probes which enables isolation of the resulting hybrids; and wherein (c) after hybridization, the test hybrid and standard hybrid are separated when necessary and the attached label is measured and the number of nucleic acid molecules per given unit is obtained by comparing the test and standard nucleic acid numbers .
The present Invention provides also a reagent kit for use in such a method, the kit comprising at least one test probe pair and at least one standard probe pair, the detector probes of both the test probe pair and the standard probe pair being labelled with a suitable label and the capturing probes having been affixed to a suitable carrier or a substance having been affixed to the capturing probes, enabling isolation of sandwich hybrids.
In. the present contextt a nucleic acid molecule is considered to be of a size ranging from a sequence of 10 - 12 nucleotides to a gene containing several thousand nucleotides. It can also mean a messenger RNA or a nucleotide sequence considerably longer than a single gene, i.e. an amplicone.
In the method of the invention, the determination of test and standard nucleic acids is carried out using an otherwise normal sandwich hybridisation described, for example, in U.S. Patent No. 4,485,539 or a solution hybridisation described in British Patent Application No. GB 2,169,403. Such sandwich and solution hybridization have the distinction of being quantitative (Virtanen et al., Lancet .1, pp. 381-383, 1983).
The reagents, or probes, used in the method of the invention may be prepared using recombinant-DNA techniques, from nucleic acids sufficiently homologous to the test and standard nucleic acids. Sufficiently homologous nucleic acids can also be prepared synthetically and semisynthatically.
The test and standard nucleic acids may be isolated directly from cells and identified by various hybridization techniques. Such test and standard nucleic acids are however also available commercially and from various gene banks. Test and standard nucleic acid may be either DNA or RNA.
Probe pairs suitable for the sandwich or solution hybridization are prepared from nucleic acids sufficiently homologous to the test and standard nucleic acids by recombinant-DNA techniques. The relevant nucleic acids are digested by suitable restriction enzymes; at least two of the resulting restriction fragments situated relatively close together are cloned to at least two suitable vectors. One of the fragments, the detectors probe, is labelled with a suitable detectable label and the other, the capturing probe, is either affixed to a suitable carrier or an substance is affixed to it, which substance enables separation of the resulting hybrid from the hybridization mixture by means of another substance, such as the complementary component of an affinity pair.
The test and standard probe pairs can be assembled into suitable reagent kits wherein the test and standard probe pairs are both DNA or RNA, or the test probe pair is DNA and the standard probe pair RNA or vice versa. The pre- and further treatment of samples prior to hybridization and the hybridization conditions should therefore comply with the probe pairs used in the test.
The method of the present invention is particularly suitable for determining the number of nucleic acid molecules directly from cellular homogenates. The method may of course also be used for the determination of purified or pure nucleic acids. However, before carrying out the method of the invention, the most suitable pretreatment of the nucleic acid sample should be selected» It is possible to carry out both DNA and RNA determinations using the method of the invention. Deoxyribonucleic acids are denatured to obtain single strands if necessary. Singlestranded messenger RNA molecules potentially disturbing the hybridization test can be hydrolyzed, for example by alkaline boiling. The sample is not denatured in connection with ribonucleic acid determinations since the double-stranded deoxyribonucleic acid does not interfere with RNA determination. It is of course possible to disrupt the DNA with deoxyribonuclease or alter it either chemically or mechanically so that it cannot participate in the hybridization reaction. Therefore in connection with DNA and RNA determinations a suitable method for further treatment of the sample must be selected or, alternatively, this further treatment may be omitted. The choice of a suitable method for the further treatment is of course dependent on the method used for the preliminary treatment of the nucleic acid sample.
Numerous methods of pre- and further treatment of nucleic acid samples have been described in the literature,, enabling the most suitable method to be chosen in each case.
Determinations in which both the test and standard nucleic acids are either DNA or RNA can be performed using an undivided sample. Determinations in which the test nucleic acids are DNA and the standard nucleic acids RNA or vice versa must be performed using a divided sample, as different methods for further treatment are necessary. The sample may of course be divided even if the test and standard nucleic acids are of the same nucleic acid type.
The hybridisation test itself is performed by bringing the undivided sample solution into contact simultaneously with at least one test probe pair and one standard probe pair. If the sample solution has been divided it is brought separately into contact with at least one test probe pair and one standard probe pair. In such instances, the quantity of test nucleic acid is determined in one reaction vessel and the quantity of the standard nucleic acid in the other.
Regardless of whether the sample is divided or notf hybridisation is allowed to take place in the most advantageous conditions and time in each case. Once the reaction(s) has/have taken place, the resulting test and standard hybrids are separated from the hybridisation mixture(s) by the carrier and washed, or by an isolation agent such as the complementary member of an affinity pair. The label attached to the test and standard hybrids is measured and the result compared with standard curves. In this way the number of nucleic acid molecules to be studied can be determined per selected unit.
The method of the invention is of practical diagnostic value, particularly in the detection of some types of cancer. In small cell lung carcinoma, the c-myc gene is often amplified and its level of expression considerably higher than in normal tissue. In cases of neuroblastoma the N-myc gene is amplified.
The method of the present invention can also be used for demonstrating the mutagenic or carcinogenic effects of certain agents or the development of drug resistance. It is known that external pressure of selection can result in enhanced expression of a certain gene. In the treatment of cancer, cells develop resistance to a given drug by amplification of the gene, the expression product of which inactivates the drug. One such case is methotrexate which induces amplification of the gene for dihydrofolate reductase (DHFR). A further example is amplification of the gene for metallothionine under the influence of cadmium.
The expression level of a gene is important from the point of view of the phenotype and function of the cell. This can be investigated by measuring the quantity of messenger RNA which correlates to the quantity of protein coded by it. The transcription product of an oncogene determines the way in which it will ultimately be expressed.
The expression levels of an oncogene vary depending on the cell type, differentiation level and phase of development of the cell. For example, at a certain, stage of fetal development, the c-myc oncogene is copied rapidly, whereas at another stage this is very slow. The degree of amplification often correlates with the level of expression of the gene, although the latter may significantly increase without the former. In such instances the role of an oncogene is best determined by measuring its level of expression rather than the number of copies. In some instances, quantitative determination of the messenger RNA may be simpler and handier than quantification of the gene product itself. As an example the c~myc oncogene, a labile protein readily coagulated by heat, can be mentioned.
The method of the invention can also be used for identifying numerical chromosomal abnormalities such as Down's syndrome. In prenatal diagnostics it is also possible to determine whether the fetus is defective, i.e. homozygous for some recessive gene.
The method of the invention and the nucleic acid reagents used in the method are described in greater detail below.
EXAMPLE 1 .Quantification of am amplified oncogen® a) Nucleic acid reagents and their preparation STANDARD PROBES Cell standard nucleic acid.. The c-Ki-rasI gene is present in all human cells. The probe pairs for sandwich hybridization were prepared by subcloning the HindiII fragment of the c-Kiras I gene, measuring 3.8 kb in length, the restriction map of which has been described by Chang et al., PNAS 79, pp. 484852, 1982. The fragment is available e.g. cloned into the pBR322 plasmid (ATCC 41032) and can be obtained e.g. from the ATCC culture collection.
Further treatment of the cell . standard nucleic acid. The pBR322 clone described above was treated with Bglll and HindiII restriction enzymes and the resulting fragments were isolated from the agarose gel; purified fragments located close together were subcloned into two suitable vectors for preparation of the detector and capturing probes.
Standard detector -probe, A Bglll-Bglll fragment measuring about 1.1 kb in length was subcloned into the BamHI restriction enzyme site of the pBR322 plasmid and labelled by nick-translation with 125I-lahelled dCTP.
Standard capturing probe. The Bgl II-Hindl 11 fragment of about 0.5 kb was inserted into the M13 mplO and mpll phage vectors between the restriction sites of BamHI and Hindlll restriction enzymes and affixed to a nitrocellulose filter (150 ng DNA/dia 1 cm).
TEST PROBES Test, nucleic acid-. A probe pair for sandwich hybridization was prepared from a cloned c~myc gene which can be obtained for example, from the ATCC culture collection (ATCC 41010). The restriction map of gene has been described by Watt et al,, PNAS 80, pp. 5307-6311, 1983.
Further. treatment of the test nucleic acid. The c~myc gene was treated with Hindlll, Xbal and Pstl restriction enzymes and the fragments isolated from the agarose gel, purified and subcloned into suitable vectors in order to prepare the detector and capturing probes.
Test detector probe.. The single-stranded tails of the HindiII-Xbal restriction fragment of the c-myc gene, measuring 3.7 kb in length, were rendered double-stranded by DNA polymerase. The Hindlll linkers were inserted by T4-DNAligase into the resulting blunt-end DNA fragments; after phenol extraction the DNA was treated with the Hindlll restriction enzyme. The DNA fragment was subsequently cloned into the pBR322 plasmid at the restriction site of the Hindlll restriction enzyme and labelled by nick-trans lation with 1251labelled dCTP.
Test capturing, probe. The 1.1 kb Xbal-Pstl fragment of the c-myc gene was cloned into the M13 mplO and mpll phage cloning vectors between the restriction sites of the Xbal and Pstl restriction enzymes and affixed to the nitrocellulose filter (150 ng DNA/dia 1 cm) . b) Determination of the standard curve.
The sample used for determination of the standard curve consisted of an alkaline-denatured pBR322 clone of the c-myc gene. The sandwich hybridization solution to which the above test probes were added consisted of 4 x SSC, 1 x Denhardt solution, 200 Mg/ml herring sperm DNA and 0.2 % SDS.
Hybridization took place at 65°C for 17 - 19 hours, whereafter the filters were washed in the wash solution (0.1 x SSC 0.2 % SDS) at 50°C. The label attached to the sandwich hybrids was then counted in the gamma counter.
Table 1 53Mpl® molecules;/test com c-mtyc-f liter 0 40 10s 75 5 χ 10δ 190 107 340 108 2200 c) Determination of the _ nwibeg of genes ., The samples comprises 1) cells from a human placenta and 2) Colo 320 cells, which can be obtained e.g. from the ATCC culture collection (ATCC-CCC220). DNA was isolated from both samples, and the same quantity of cell DNA, denatured by alkaline boiling, was added to both tests. Alkaline denaturation hydrolyzed any RNA present in the sample.
The test was performed by adding to each sample both the c-myc and c-Ki-rasI filters and the two labelled reagents, enabling both the standard and test DNA to be measured for each sample. On the basis of c-Ki-rasI determinations, each test was found to contain the same quantity of DNA and it can be deduced that the c-myc gene in Colo 320 cells is present in about 16 - 20 higher copy number than in the normal situation. The results are shown in Table 2.
Table 2 Sample c-Ki-rasI filter c-wc filter cpm* cw* number Human placental cells 486 340 107 Colo 320 cells 432 3205 1.6 χ 108 *the reading obtained from the blank filter has been subtracted from the readings.
EXAMPLE 2 Quantification of amplified gene a) Nucleic acid reagents and their preioaraxion STANDARD PROBES Cell standard nucleic .acid. The control nucleic acid was taken from the promoter area of the metallothionine gene in the mouse,, i.e. the MT gene, and the DNA immediately upstream of it. The structure of the MT gene has been described by Pavlakis and Hamer, PNAS ,80, pp. 397-401, 1983. The reference nucleic acid fragments is available e.g. cloned into the pBPVMMTneo(432-12) vector (ATCC 37224) and can be obtained, for example, from the ATCC culture collection.
Further treatment.· of cell staaidard nucleic acid. The MT gene described above was treated with Kpnl, Bglll and EcoRI restriction enzymes for subcloning into the pAT153 plasmid. The Kpnl tail was converted into a HindxII tail with a linker.
Standard detector orohe. The EcoRI-Kpnl-(Hindlll) fragment measuring about 1.2 kb and located upstream of the promoter area of metallothionine gene was cloned to the pAT153 plasmid between the restriction sites of the EcoRI and HindiII restriction enzymes and labelled by nick-translation with 3Zp-labelled nucleoside triphosphates.
Standard capturing The 0.8 kb ΚρηΙ-BglII fragment comprising the promoter area of the metallothionine gene and the area upstream of it was cloned into the M13 mpl8 and Ml3 mpl9 phage vectors between the restriction sites of the Kpnl and BamHI restriction enzymes and affixed to the nitrocellulose filter.
TEST PROBES Test nucleic acid. The probe pair for the sandwich hybridization test was prepared using the commercially available pMTVdhfr plasmid (Bethesda Research Laboratories, product No. 5369SS), the structure of which is described by Lee et al., Nature 294, pp. 228-232, 1981.
Further treatment of test nucleic acid. The pMTVdhfr plasmid containing cDNA of the dihydrofolate reductase (DHFR) gene was treated with HindiIϊ and Bglll restriction enzymes.
Test detector probe. The Hindlll-Bglll fragment, measuring 0.75 kb and corresponding to the area coding for the DHFR gene of the pMTVdhfr plasmid, was inserted into the plasmid pAT153 vector between the restriction sites of the HindiII and BamHI restriction enzymes and labelled by nick-translation with 32P-labelled nucleoside triphosphates.
Test caotwrinor probe. A Hindlll fragment measuring 1.4 kb taken from the MMTV gene area of the pMTVdhfr plasmid was cloned into the M13 mpl8 and M13 mpl9 phage vectors. b) PeteraaLination of the standard curve The sample used for the test was purified DNA from the pMTVdhfr plasmid. The test itself was carried out as described in Example lb except that a liquid scintillation counter was used for counting. The resulting standard curve is shown in Table 3.
Table 3 Samole corn molecules/test DHFR filter 0 17 10s 45 3 x 10s 79 107 210 c) Determination of the am&er, of cremes Cell lines (derived from the mouse fibroblast cell N1H 3T3 and available from the ATCC culture collection under the number CRD 1658) which has been transfected with different quantities of cDNA corresponding to the mRNA of the DHFR gene were cultured on cell culture plates and used as the sample. The cells were lysed using sodium dodecyl sulphate and their DNA was sheared by squeezing through a fine hypodermic needle from a syringe. A 250 μΐ sample corresponding to about 106 cells was taken from the homogenate and 50 μΐ NaOH added. The sample was boiled and neutralized with acetic acid and the hybridization mixture. The total volume was 0.5 ml. All the probes described above were added simultaneously and a socalled blank filter was added as a background control. Hybridization, washing and label counting were done as in Example lb except that a liquid scintillation counter was used for counting. The results are shown in Table 4 .
IS Table 4- Call MT ¢40. ai eatts mm cam* in th® ean’ ¢40. es moteadss ¢40. c: ist As samps»» Cap'S® Cosnral csil (hio mt=F^eOm) 22 1.03 x 1G8 21 < IC? - Lists 1 138 0.S X id® CD 3si id* 3 Uew II 210 X 10s 7S2 5x 107 40 * cpm: the reading given by the blank filter has been subtracted.
The MT gene is an internal marker which measures the number of cells present in a sample. The results show that in this test 106 cells gave an MT-specific signal of 165 + 20 cpm. The DHFR reagents measure the quantity of DHFR-cDNA. The number of cells was deduced from the MT-specific signal. It was thus possible to determine the number of DHFR-cDNA copies in different cell lines as shown in Tabla 4.
ESAMPLS 3.
Quantification of messenger RNA a) Nucleic acid reagents and their preparation Using the test probes described in Example 2 it is also possible to measure the quantity of mRNA derived from DHFRcDNA. The structure of the pMTVdhfr plasmid is such that transcription of the DHFR gene begins at the MMTV promoter. The resulting messengers are about 1.0 kb in length. Of this, about 0.25 kb are derived from the MMTV promoter area and the rest from DHFR-cDNA (Lee et al., Nature 294, ρρ. 228-232, 1981).
STANDARD PROBES The cell standard nucleic acid, standard detector and standard capturing probe were as described in Example 2.
TEST PROBES The test nucleic acid, test detector and test capturing probe were as described in Example 2. b) D@termd.:aatiosl· of the standard curve The sample used for standard curve determination consisted of messenger RNA corresponding to the dihydrofolate reductase gene produced by in vitro transcription. The DNA needed for transcription was prepared by subcloning the 1.4 kb HindlH fragment of the MMTV promoter of the pMTvdhfr plasmid and the 0,75 kb Hindlll-Bglll fragment (DHFR-cDNA) next to each other into the pSP64 plasmid (Promega Biotec) between the restriction sites of the HindlH and BamHI restriction enzymes. The sample RNA was stored in 0.2 % SDS aqueous solution.
The sandwich hybridization test was carried out as described in Examples lb and 2b but denaturation was omitted.
Table 5 Sarnole molecules/test com DHFR filter 0 20 5 χ 10δ 65 107 130 5 χ 107 390 10s 653 c) Determination of the number of Bbesseaoer RHIA molecules The number of. messenger RNA molecules corresponding to the DHFR gene was determined from the cell lines described in Example 2.
The cells were lysed using sodium dodecyl sulphate and their DNA was sheared slightly by squeezing through a fine hypodermic needle from a syringe. A 250 μΐ sample of the homogenate was taken corresponding to about 5 χ 106 cells. The homogenate was then added to the sandwich hybridization test without denaturation. Sandwich hybridization took place as described in Examples 2c and lb, except that only the DHFR probes were added to the hybridisation solution. In a parallel sample of 250 μΐ of homogenate, the cell number was determined using the MT probe as described in Example 2c.
The results are shown in Table β.
Table δ Cei ΜΐΓ epes® Os· «wjCKTsr to ift® swwto DHFR esa* Six e# «ifeoAs to tJ&e sampfe Ife. P*3i &cfl llto© IJ 390 as x mi 11465 345x t©5 « 10» HI 430 <2 x -4300 2 x lie? see 10 *cpm: The reading given by the blank filter has been subtracted.
The results showed that cell line I produced per cell about 100 messenger RNA molecules from the DHFR genes and cell line II produced about 500 messenger RNA molecules from the DHFR genes.
EXAMPLE 4.
Quantification of amplified gene by solution hybridization. a) Nucleic .acid reagents and their preparation STA3HDASD PROBES The cell standard nucleic acid, standard detector and standard capturing probe were as described in Example 2. The 1.2 kb EcoRI-Kpnl-(Hindlll) fragment in pAT153 was labelled by nick·· translation with 125I-labelled deoxycytidine. The 0.8 kb KpnlBglll fragments in ill3 mpl8 and Ml3 mpl9 were modified with biotin using the Photoprobe™ reagent (Vector Laboratories, CA, USA, product No SP-1000).
TEST PROBES The test nucleic acid, test detector and test capturing probe were as described in Example 2. The 0.75 kb Hindlll-Bglll fragment in pAT153 was labelled with 125I-labelled deoxycytidine. The 1.4 kb HindlH fragments in M13 mpl8 and Ml3 mpl9 were biotinylated using Photoprobe™ as above. b) Determination of the standard curves A cell standard curve was prepared using a known amount of cells, from which the hybridization signal was measured using the standard probes recognizing the MT-gene. A test nucleic acid standard curve was prepared with the pMTVdhfr plasmid and the test probes recognizing this plasmid. Hybridizations were carried out in 200 μΐ of a solution consisting of Ο.β M NaCl, 20 mM phosphate buffer, pH 7.5, 1 mM EDTA, 4% polyethylene glycol (PEC 6000) for 1.5 hours at 70°C. After the reaction 50 μΐ of streptavidin-agarose (Betheseda Research Laboratories, Maryland, USA, product No. 5942SA), and 1 M NaCl, 10 mM sodium phosphate, pH 7.5, 1 mM EDTA was added to a final volume of 500 μΐ. The hybrids were collected on the streptavidinagarose at 37°C for 15 min. The agarose was washed once for 5 min. with the buffered 1 M NaCL solution at 37°C and twice for 2 min. with 15 mM NaCl, 1.5 mM sodium citrate at 55°C. The amount of bound hybrids was determined by measuring the agarose in a gamma counter. (Syvanen et al., Nucleic Acids Res. 14., 5037-5048, 1986). The results are shown in table 7 and 8.
Table 7 Sasrole con® cells/test MT probes 0,8 x 10s 162 1,6 x 106 216 3 x 10s 298 Table 8 .Sasroie molecules/test DHFR probes 10s 148 5 x 10s 394 5 x 107 2240 c) Determination of the number of ©panes..
Samples of the cell lines described in Example 2 were treated in a similar way, except that the volume per sample corresponding to approximately 2 x 106 cells was 125 μΐ. The determinations of number of cells and number of test nucleic acid molecules were carried out in separate vials by adding the cell sample, the appropriate detector and capturing probes, and the components of the hybridization mixture to a final volume of 200 μΐ. Control assays without cell standard or test DNA were included. Hybridization, collection of hybrids, washing and measurement was done as described in Example 4b. The results were read from standard curves prepared in parallel as described in Example 4b. The results are shown in Table 9.
Table 9 _ Cell MT DHFR cpe* No of cells in the sample com* SiO. of No. of Molecules copies in the sample Control cell 253 2.3 x 10s 73 < I05 - Lin© I 210 1.5 x 10s 233 3.8 x 10s 3 Line II 237 2.1 x 10s 3059 8.8 x IO7 42 * cpsas values from control assays without cell standard or test nucleic acid have been subtracted-

Claims (14)

1. A quantitative method for the determination of nucleic acid molecules by sandwich or solution hybridization, the method comprising determining the number of nucleic acid molecules per given unit by comparing the number of test nucleic acid molecules potentially present in several copies in the unit to the number of chosen standard nucleic acid molecules advantageously present in a constant number in the same unit, wherein the nucleic acids present in the sample (a) are rendered, if necessary, into a form whereby they can participate in the hybridization reaction, any nucleic acids potentially disturbing the hybridization reaction being rendered, if necessary, into a form whereby they cannot interfere with the hybridization test; and (b) are brought into contact, either undivided or, when necessary divided, with at least one test probe pair sufficiently homologous to the nucleic acid potentially present in several copies and with at least one chosen and suitable standard probe pair sufficiently homologous to the nucleic acid molecule advantageously present in a constant number, the detector probes of the test probe pair and standard probe pair being labelled with a detectable label and the capturing probes having been affixed to a suitable carrier or a substance having been affixed to the capturing probes which enables isolation of the resulting hybrids, and wherein (c) after hybridisation, the test hybrid and standard hybrid are separated when necessary and the attached label is measured and the number of nucleic acid molecules per given unit is obtained by comparing the test and standard nucleic acid numbers.
2. A method according to claim 1, wherein the test and standard nucleic acids are deoxyribonucleic acids.
3. A method according to claim 1, wherein the test nucleic acid is ribonucleic acid and the standard nucleic acid is deoxyribonucleic acid.
4. A method according to claim 1, wherein the test and standard nucleic acids are ribonucleic acids. 5. Detector probe of the test probe pair is a recombinant plasmid comprising a 0.75 kb Hindlll-Bglll fragment coding for the DHFR gene of the pMTVdhfr plasmid, the fragment having been subcloned into the pAT153 plasmid vector between the restriction sites of the HindiIX and
5. A method according to claim 1, wherein the test nucleic acid is deoxyribonucleic acid and the standard nucleic acid is ribonucleic acid. δ.
6. A method according to any one of claims 1 to 3, wherein the detector probe of the standard probe pair is a recombinant plasmid comprising a 1.1 kb BglH-BglH fragment of the HindHI fragment of the human c-Ki-rasI gene, the HindHI fragment being cloned into the pBR322 plasmid and the Bglll-Bglll fragment being subcloned into the restriction site of the BamHl restriction enzyme of the pBR322 plasmid, and the capturing probes are recombinant phages comprising a 0.5 kb BglH-HindiII fragment of the HindHI fragment of the human c-Ki-rasI gene, the HindHI fragment being cloned into the pBR322 plasmid and the Bglll-Hindlll fragment being subcloned into the Ml 3 mplO and Ml 3 mpll phage vectors between, the restriction sites of the BamHl and HindHI restriction enzymes and wherein the probes are brought, either individually or together with the test probe pair, into contact with an undivided or when necessary divided nucleic acid sample.
7. A method according to any one of claims 1 to 3, wherein the detector probe of the standard probe pair is a recombinant plasmid comprising a 1.2 kb EcoRIKpnl(Hindili) fragment from upstream of the promoter area of the mouse metallothionine gene, which fragment has been subcloned into the pAT153 plasmid between the restriction sites of the EcoRI and Hindili restriction enzymes, and the capturing probes are recombinant phages comprising a 0.8 kb ΚρηΙ-BglII fragment from the promoter arsa of the metallothionine gene and the area upstream of it, the fragment having been subcloned into the Ml3 mp!8 and Ml3 mpl9 phage vectors between the restriction sites of the Kpnl and BamHI restriction enzymes, and wherein the probes are brought, either individually or together with the test probe pair, into contact with an undivided or when necessary divided nucleic acid sample.
8. A method according to claim S or claim 7, wherein in order to determine the degree of amplification of the c-myc oncogene and/or the number of messenger RNA molecules corresponding to that gene, the detector probe of the test probe pair is a recombinant plasmid comprising a 3.7 kb Hindlll-Xbal fragment of the c-myc gene, the fragment being subcloned into the pBR322 plasmid at the restriction site of the Hindili restriction enzyme, and the capturing probes are recombinant phages comprising a 1.1 kb Xbal-Pstl fragment of the c-myc gene, the fragment having been subcloned into the Ml 3 mplO and Ml 3 mpll vectors between the restriction sites of the Xbal and Pstl restriction enzymes, and wherein the probes are brought, either individually or together with the standard probe pair, into contact with an undivided or when necessary divided nucleic acid sample.
9. A method according to claim S or claim 7, wherein in order to determine the degree of amplification of the dihydrofolate reductase or DHFR gene and/or the number of messenger RNA molecules corresponding to that gene, the
10. A reagent kit for the quantitative determination of 20 nucleic acid molecules by the method of claim 1, the kit comprising at least one test probe pair and at least one standard probe pair, the detector probes of both the test probe pair and the standard probe pair being labelled with a suitable label and the capturing probes having 25 been affixed to a suitable carrier or a substance having been affixed to the capturing probes, enabling isolation of sandwich hybrids. 10 BamHI restriction enzymes, and the capturing probes are recombinant phages comprising a 1.4 kb HindlH fragment of the MMTV gene area of the pMTVdhfr plasmid, the fragment having been subcloned into the Ml3 mpl8 and Ml3 mpl9 phage vectors at the restriction site of the HindiII 15 restriction enzyme and wherein the probes are brought, either individually or together with the standard probe pair, into contact with an undivided or when necessary divided nucleic acid sample.
11. A reagent kit according to claim 10, wherein the detector probe of the test probe pair used for the determination 30 of the degree of amplification of the c-myc oncogene and/or the number of messenger RNA molecules corresponding to that gene is a recombinant plasmid comprising a 3.7 kb Hindlll-Xbal restriction fragment of the c-myc gene, the fragment having been subcloned into the pBR322 plasmid at the restriction, site of the Hindi 11 restriction enzyme, the capturing probes are recombinant phages comprising a 1.1 kb Xbal-Pstl fragment of the c-myc gene, the fragment having been subcloned into the Ml 3 mplO and Ml 3 xnpll phage vectors between the restriction sites of the Xbal and Pstl restriction enzymes, the detector probe of the standard probe pair is a 1.1 kb Bglll-Bgll'I fragment of the Hindi 11 fragment of the human c-Ki~rasI gene, the Hindlll fragment having been cloned into the pBR322 plasmid and the Bglll-Bglll fragment having been subcloned into the pBR322 plasmid at the restriction site of the BamHI restriction enzyme, and the capturing probes are recombinant phages comprising a 0.5 kb BgllX-Hindlll fragment of the Hindlll fragment of the c-Ki-ras! gene, the Hindlll fragment having been subcloned into the pBR322 plasmid of the c-Ki-rasI gene, and the Bglll-Hindi 11 fragment having been subcloned into the Ml3 mplO and Ml3 mpll phage vectors between the restriction sites of the BamHI and Hindlll restriction enzymes .
12. A reagent kit according to claim 10, wherein the detector probe of the test probe pair used for determination of the degree of amplification of the dihydrofolate reductase of DHFR gene and/or the number of messenger RKA molecules corresponding to that gene is a recombinant plasmid comprising a 0.75 kb HindiII-Bglll fragment coding for the DHFR gene of the pMTVdhfr plasmid, the fragment having been subcloned into the pAT!53 plasmid vector between the restriction sites of the Hindlll and BamHI restriction enzymes, the capturing probes are recombinant phages comprising a 1.4 kb Hindlll fragment of the MMTV gene area of the pMTVdhfr plasmid, the fragment having bean subcloned into the Ml3 rap 18 and Ml3 mpl9 phage vectors at the restriction site of the Hindlll restriction enzyme, the detector probe of the standard probe pair is a recombinant plasmid comprising a 1.2 kb EcoRI-Kpnl fragment from upstream of the promoter area of the mouse metallothionine gene, the fragment having been subcloned into the OAT153 plasmid between the restriction sites of the EcoRI and Hindlll restriction enzymes, and the capturing probes are recombinant phages comprising a 0.8 kb Kpnl-Bglll fragment of the metallothionine gene formed by the promoter area and the area upstream of it, the fragment having been subcloned into the Ml 3 mpl8 and Ml 3 mpl9 phage vectors between the restriction sites of the Kpnl and BamHI restriction enzymes.
13. A method according to claim 1, substantially as hereinbefore described.
14. A reagent kit according to claim 10, substantially as hereinbefore described.
IE49687A 1986-02-27 1987-02-26 Qantification of nucleic acid molecules and the reagent Kit Used IE66904B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI860836A FI76119C (en) 1986-02-27 1986-02-27 Quantitative determination of nucleic acid molecules and reagent packaging used in the process

Publications (2)

Publication Number Publication Date
IE870496L IE870496L (en) 1987-08-27
IE66904B1 true IE66904B1 (en) 1996-02-07

Family

ID=8522222

Family Applications (1)

Application Number Title Priority Date Filing Date
IE49687A IE66904B1 (en) 1986-02-27 1987-02-26 Qantification of nucleic acid molecules and the reagent Kit Used

Country Status (26)

Country Link
JP (1) JPS62205800A (en)
KR (1) KR870008033A (en)
AT (1) AT393511B (en)
AU (1) AU603562B2 (en)
BE (1) BE1001168A4 (en)
CA (1) CA1287558C (en)
CH (1) CH675593A5 (en)
DD (1) DD270383A5 (en)
DE (1) DE3706285A1 (en)
DK (1) DK174784B1 (en)
ES (1) ES2061411A6 (en)
FI (1) FI76119C (en)
FR (1) FR2594849B1 (en)
GB (1) GB2187283B (en)
HU (1) HU201808B (en)
IE (1) IE66904B1 (en)
IL (1) IL81695A (en)
IS (1) IS3197A7 (en)
IT (1) IT1202581B (en)
LU (1) LU86792A1 (en)
NL (1) NL195097C (en)
NO (1) NO175380C (en)
NZ (1) NZ219421A (en)
PT (1) PT84368B (en)
SE (1) SE468816B (en)
ZA (1) ZA871401B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714380A (en) 1986-10-23 1998-02-03 Amoco Corporation Closed vessel for isolating target molecules and for performing amplification
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Method and kits for the amplification and detection of nucleic acid sequences
EP0304845A3 (en) * 1987-08-28 1991-03-06 Profile Diagnostic Sciences Inc. Method and kit for assaying gene expressions
DE68921918T2 (en) * 1988-05-09 1995-09-07 Univ Temple Procedure for predicting the effectiveness of antineoplastic treatment in individual patients.
AU629845B2 (en) * 1988-08-30 1992-10-15 Abbott Laboratories Detection and amplification of target nucleic acid sequences
AU5731790A (en) * 1989-05-18 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Rna probe for detecting c-fes mrna
US5232829A (en) * 1989-09-29 1993-08-03 Hoffmann-La Roche Inc. Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
DK138090D0 (en) * 1990-06-06 1990-06-06 Novo Nordisk As DIAGNOSTIC METHOD OF ANALYSIS
DE69214243T2 (en) * 1991-09-23 1997-02-06 Pfizer Methods for the detection of specific mRNA and DNA in cells
US6300058B1 (en) 1992-01-29 2001-10-09 Hitachi Chemical Research Center, Inc. Method for measuring messenger RNA
GB9210916D0 (en) * 1992-05-21 1992-07-08 Isis Innovation Nucleic acid quantification
CA2140763A1 (en) * 1992-07-28 1994-02-03 Masato Mitsuhashi Gene detection system
US5580971A (en) * 1992-07-28 1996-12-03 Hitachi Chemical Company, Ltd. Fungal detection system based on rRNA probes
ES2055661B1 (en) * 1993-01-20 1995-03-01 Univ Malaga DETERMINATION OF THE GENE EXPRESSION BY SPECIFIC CAPTURE OF RNA AND ITS DIRECT QUANTIFICATION BY CAPILLARY ELECTROPHORESIS IN A FREE ZONE.
GB9309966D0 (en) * 1993-05-14 1993-06-30 Nordion Int Inc Detection of prostrate-specific antigen in breast tumors
GB9415489D0 (en) * 1994-08-01 1994-09-21 Nordion Int Inc Detection of prostate-specific antigen in amniotic fluid
AT401062B (en) * 1994-09-26 1996-06-25 Immuno Ag Method for quantifying nucleic acids
JP5565781B2 (en) 2010-03-31 2014-08-06 有限会社山口ティー・エル・オー Method for detecting pneumonia-causing bacteria using nucleic acid chromatography

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442203A (en) * 1981-06-30 1984-04-10 Massachusetts Institute Of Technology Gene amplification assay for detecting tumor promoters
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
AU555146B2 (en) * 1982-03-15 1986-09-11 Trustees Of Columbia University In The City Of New York, The Method for intorducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products materials
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
FI71768C (en) * 1984-02-17 1987-02-09 Orion Yhtymae Oy Enhanced nucleic acid reagents and process for their preparation.
US4675283A (en) * 1984-07-19 1987-06-23 Massachusetts Institute Of Technology Detection and isolation of homologous, repeated and amplified nucleic acid sequences
FI72146C (en) * 1985-01-02 1987-04-13 Orion Yhtymae Oy Procedure for Identifying Nucleic Acids.
FR2583771B1 (en) * 1985-06-21 1988-12-09 Centre Nat Rech Scient DNA SEQUENCES OF ARCHAEBACTERIA HOMOLOGATED TO ONCOGEN V-MYC, PROTEINS ENCODED BY THESE SEQUENCES, PROCESSES FOR OBTAINING SAME AND IMMUNOLOGICAL APPLICATIONS

Also Published As

Publication number Publication date
AU603562B2 (en) 1990-11-22
CH675593A5 (en) 1990-10-15
PT84368A (en) 1987-03-01
DK174784B1 (en) 2003-11-10
FR2594849A1 (en) 1987-08-28
HU201808B (en) 1990-12-28
PT84368B (en) 1989-10-04
AT393511B (en) 1991-11-11
FI860836A (en) 1987-08-28
ATA43187A (en) 1991-04-15
JPS62205800A (en) 1987-09-10
FR2594849B1 (en) 1990-04-20
DD270383A5 (en) 1989-07-26
GB2187283B (en) 1990-05-30
NL8700483A (en) 1987-09-16
NO870794D0 (en) 1987-02-26
NO175380C (en) 1994-10-05
IT1202581B (en) 1989-02-09
GB8704517D0 (en) 1987-04-01
BE1001168A4 (en) 1989-08-08
HUT43647A (en) 1987-11-30
IT8719501A0 (en) 1987-02-26
ES2061411A6 (en) 1994-12-01
DK99387A (en) 1987-08-28
LU86792A1 (en) 1987-07-24
ZA871401B (en) 1987-10-28
SE468816B (en) 1993-03-22
NO175380B (en) 1994-06-27
DK99387D0 (en) 1987-02-26
CA1287558C (en) 1991-08-13
NL195097C (en) 2004-03-17
FI860836A0 (en) 1986-02-27
FI76119C (en) 1988-09-09
DE3706285A1 (en) 1987-11-12
KR870008033A (en) 1987-09-23
JPH0561920B2 (en) 1993-09-07
IL81695A (en) 1991-04-15
NZ219421A (en) 1988-11-29
NO870794L (en) 1987-08-28
GB2187283A (en) 1987-09-03
AU6927587A (en) 1987-09-03
SE8700821L (en) 1987-08-28
IS3197A7 (en) 1987-08-28
IL81695A0 (en) 1987-09-16
FI76119B (en) 1988-05-31
IE870496L (en) 1987-08-27
SE8700821D0 (en) 1987-02-26
DE3706285C2 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
IE66904B1 (en) Qantification of nucleic acid molecules and the reagent Kit Used
US4946773A (en) Detection of base pair mismatches using RNAase A
EP0444115B2 (en) In situ suppression hybridization and uses therefor
Christianson et al. Identification of multiple transcriptional initiation sites on the yeast mitochondrial genome by in vitro capping with guanylyltransferase.
Klein et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
US5645990A (en) Identification and paternity determination by detecting presence or absence of multiple nucleic acid sequences
CN105838777A (en) Method for monitoring secondary drug resistance of lung cancer patient to tyrosine kinase inhibitor through ddPCR technology
Sollner et al. Accurate transcription of cloned Xenopus rRNA genes by RNA polymerase I: demonstration by S1 nuclease mapping
Uryu et al. Research note: Determination of the sex of chickens by a biotin-labeled deoxyribonucleic acid probe
WO2017114011A1 (en) Her-2 gene and/or top2a gene detection probe, preparation method therefor, and test kit
Kalkuhl et al. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ betweenRas-mutated andRas-wild-type lesions
EP0172153A1 (en) Polynucleotide hybridization probes
Minkley Jr Transcription of the early region of bacteriophage T7: specificity and selectivity in the in vitro initiation of RNA synthesis
WO2017114010A1 (en) Top2a gene detection probe, preparation method therefor, and test kit
Markovic et al. A sensitive method for the detection of poly‐A tails of mRNA using a biotin‐labelled heteropolymer of dT: rA
Tsuchiya et al. Characterization of a DNA uptake reaction through the nuclear membrane of isolated yeast nuclei
Ludwig et al. Measurement of mRNA by solution hybridization with 32P-labelled single stranded cRNA probe (“SP6 test”). Comparison with a 32P-labelled single stranded cDNA as hybridization probe (“S1 test”) for measurement of AVP mRNA
WO1998048277A1 (en) A sensitive method for measurement of telomeric dna content in human tissues
Bahramian et al. Direct gene quantitation by PCR reveals differential accumulation of ectopic enzyme in rat-1 cells, v-fos transformants, and revertants.
CN117248017A (en) Human NRAS gene mutation detection kit and application thereof
Goldenthal Isolation and Characterization of Mitochondrial RNA Polymerase from Drosophila Melanogaster

Legal Events

Date Code Title Description
MK9A Patent expired